Back to top

Tale of the Tape

Zacks Equity Research

MEI Pharma (MEIP) Looks Good: Stock Adds 5.7% in Session
October 04, 2016


Trades from $3

MEI Pharma, Inc. (MEIP - Snapshot Report) was a big mover last session, as the company saw its shares rise roughly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.69 to $1.80 since Sep 9, 2016.

In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher over the same time frame, suggesting that more solid trading could be ahead for MEI Pharma. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

MEI Pharma currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Another well-ranked stock in the Med-Drugs industry is Ariad Pharmaceuticals Inc. (ARIA - Analyst Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MEIP going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>